Ublituximab, CAS 1174014-05-1

Product Description: Ublituximab (LFB-R603; TG-1101; TGTX-1101) is a next-generation, type 1 chimeric monoclonal antibody targeting a unique epitope on the CD20 antigen. Ublituximab has anticancer effects[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Matthew Lunning, et al. Ublituximab and umbralisib in relapsed/refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia. Blood. 2019 Nov 21;134(21):1811-1820.

CAS Number: 1174014-05-1

Molecular Weight: N/A

Compound Purity: 98.42

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: CD20

• SKU: MEXHY-P99538-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99538-5
• Package Unit: 5 mg
• Quantity Unit: STK
• Conjugate: Unconjugated